Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancers

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 4, 2013, Pages 2557-2561

  Baykara, Meltem ^a   Buyukberber, Suleyman ^b   Ozturk, Banu ^c   Coskun, Ugur ^b   Unsal, Diclehan Kilic ^b   Demirci, Umut ^d   Dane, Faysal ^e   Kaplan, Muhammet Ali ^f   Bora, Huseyin ^b   Benekli, Mustafa ^b  

^a SAKARYA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c GAZIOSMANPASA UNIVERSITY   (Turkey)

^d ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e MARMARA UNIVERSITY   (Turkey)

^f DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Chemoradiotherapy; Cisplatin; Docetaxel; Safety; Squamous cell head and neck cancers

Indexed keywords

EID: 84880296848     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.4.2557     Document Type: Article

References (39)

1. Adelstein DJ, Li Y, Adams GL, et al (2003). An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol, 21, 92-8.
2. Adelstein DJ, Lavertu P, Saxton JP, et al (2000). Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer, 88, 876-83.
3. Agarwala SS, Cano E, Heron DE, et al (2007). Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer. Ann Oncol, 18, 1224-9.
4. Bernier J, Schneider D (2007). Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck. Eur J Cancer, 43, 35-45.
5. Bourhis J, Lefebvre JL, Vermorken JB (2010). Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options. Eur J Cancer , 46, 1979-89.
6. Bourhis J, Le Maître A, Baujat B, Audry H, Pignon JP (2007). Meta-analysis of chemotherapy in head, neck cancer collaborative group; meta-analysis of radiotherapy in carcinoma of head, neck collaborative group; meta-analysis of chemotherapy in nasopharynx carcinoma collaborative group. individual patients' data meta-analyses in head and neck cancer. Curr Opin Oncol, 19,188-94
7. Brizel DM, Albers ME, Fisher SR, et al (1998). Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med, 338, 1798-804.
8. Calais G, Alfonsi M, Bardet E, et al (1999). Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst, 91, 2081-6.
9. Chitapanarux I, Lorvidhaya V, Tharavichitkul E, (2011). A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer. Auris Nasus Larynx, 38, 108-13.
10. Chougule PB, Akhtar MS, Rathore R, et al (2008). Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53). Head Neck, 30, 289-96.
11. Cmelak AJ, Li S, Goldwasser MA, et al (2007). Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol, 25,3971-7.
12. D'Souza G, Kreimer AR, Viscidi R, et al (2007). Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med, 356, 1944-56.
13. Forastiere AA, Zhang Q, Weber RS, et al (2013). Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer. J Clin Oncol, 31, 845-52.
14. Forastiere AA, Goepfert H, Maor M, et al (2003). Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med, 349, 2091-8.
15. Fornari G, Artusio E, Mairone L, et al (2002). Paclitaxel and carboplatin in neo-adjuvant and concomitant chemoradiotherapy in locally advanced head and neck squamous cell carcinoma. Tumori, 88, 489-94.
16. Garden AS, Harris J, Vokes EE, et al (2004). Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol, 22, 2856-64.
17. Haddad R, O'Neill A, Rabinowits G, et al (2013). Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol, 14, 257-64.
18. Huang J, Baschnagel AM, Chen P, et al (2007). A matched-pair comparison of intensity-modulated radiation therapy with cetuximab versus intensity-modulated radiation therapy with platinum-based chemotherapy for locally advanced head neck cancer. Int J Clin Oncol, 10, 0540.
19. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300.
20. Jeremic B, Shibamoto Y, Milicic B, et al (2000). Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol, 18, 1458-64.
21. Karasawa K, Shinoda H, Katsui K, et al (2002). Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer. Anticancer Res. 22, 3785-8.
22. Krengli M, Masini L, Gambaro G, et al (2001) Concurrent chemotherapy with carboplatin + 5-fluorouracil and radiotherapy in advanced squamous cell head and neck carcinoma: a retrospective single institution's study. Tumori , 86, 312-6.
23. Landis SH, Murray T, Bolden S, Wingo PA (1999). Cancer Statistics, 1999. CA Cancer J Clin, 49, 8-31.
24. Matsumoto F, Karasawa K, Itoh S, et al (2006). Concurrent weekly docetaxel and hyperfractionated radiotherapy for advanced head and neck cancer. Anticancer Res, 26, 3781-6.
25. Mauer AM, Masters GA, Haraf DJ, et al (1998). Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol, 16, 159-64.
26. Mencoboni M, Grillo-Ruggieri F, Salami A, et al (2011). Induction chemotherapy in head and neck cancer patients followed by concomitant docetaxel-based radiochemotherapy. Eur J Cancer Care, 20, 503-7.
27. Mencoboni M, Rebella L, Tredici S, et al (2005). Concurrent chemo-radiotherapy with taxotere and cisplatin in head and neck cancer: a feasibility study. Anticancer Res, 25, 4451-4.
28. Okami K, Hamano T, Takeo T, et al (2008). Concurrent chemoradiotherapy with docetaxel for T2 laryngeal carcinoma. Tokai J Exp Clin Med, 33, 130-4.
29. Pignon JP, le Maître A, Bourhis J (2007) MACH-NC Collaborative Group. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys, 69, 112-4
30. Pignon JP, Bourhis J, Domenge J, Designe L, MACH-NC (2000). Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Meta-analysis of chemotherapy on head and neck cancer. Lancet, 355, 949-55.
31. Ready NE, Rathore R, Johnson TT, et al (2012). Weekly Paclitaxel and Carboplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Am J Clin Oncol, 35, 6-12.
32. Schwartz DL, Montgomery RB, Yueh B, et al (2005). Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer, 103, 2534-43.
33. Suzuki M, Nishimura Y, Nakamatsu K, et al (2003). Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancer. Jpn J Clin Oncol, 33, 297-301.
34. Tishler RB, Norris CM Jr, Colevas AD, et al (2002). A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck. Cancer, 95, 1472-81.
35. Tishler RB, Posner MR, Norris CM Jr, et al (2006). Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys, 65, 1036-1044.
36. Tsao AS, Garden AS, Kies MS, et al (2006). Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. J Clin Oncol, 24, 4163-9.
37. Okami K, Hamano T, Takeo T, et al (2008). Concurrent chemoradiotherapy with docetaxel for T2 laryngeal carcinoma. Tokai J Exp Clin Med, 33, 130-4.
38. Tsao AS, Garden AS, Kies MS, et al (2006). Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. J Clin Oncol, 24, 4163-9.
39. Wendt TG, Grabenbauer GG, Rödel CM, et al (1998). Schalhorn A. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol, 16, 1318-24.